Second‐line therapy in young patients with relapsed or refractory orbital rhabdomyosarcoma

Second‐line therapy in young patients with relapsed or refractory orbital rhabdomyosarcoma

Objective Localized orbital rhabdomyosarcoma (oRMS) has an overall favourable prognosis with more than 90% of survival. Little is known about the best strategy in recurrent/refractory (R/R) cases. The purpose is to examine the characteristics of patients with R/R‐oRMS, focusing on local therapy. Met...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta ophthalmologica (Oxford, England) England), 2021-05, Vol.99 (3), p.334-341
Hauptverfasser: Zloto, Ofira, Minard‐Colin, Veronique, Boutroux, Helene, Brisse, Herve J., Levy, Christine, Kolb, Frederic, Bolle, Stephanie, Carton, Matthieu, Helfre, Sylvie, Orbach, Daniel
Format: Artikel
Sprache:eng
Schlagworte:
Alveoli
biostatistics
Brachytherapy
cancer
Chemotherapy
Confidence intervals
Life Sciences & Biomedicine
Medical prognosis
Metastases
oculoplastic
Ophthalmology
orbit
orbital rhabdomyosarcoma
Patients
Radiation therapy
Remission
Rhabdomyosarcoma
Science & Technology
Surgery
Tumors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective Localized orbital rhabdomyosarcoma (oRMS) has an overall favourable prognosis with more than 90% of survival. Little is known about the best strategy in recurrent/refractory (R/R) cases. The purpose is to examine the characteristics of patients with R/R‐oRMS, focusing on local therapy. Methods This is bicentric retrospective study. Analysis is of young patients (
ISSN:1755-375X
1755-3768
DOI:10.1111/aos.14596